Securing capital is paramount for biotechnology companies striving for exponential expansion. As the sector evolves, a deep knowledge of financial markets becomes increasingly vital. Financial institutions often seek firms with a strong track record of success and promising products. To obtain the necessary resources, biotech companies must present